Brokerages Set Tivity Health Inc (TVTY) PT at $34.00
Tivity Health Inc (NASDAQ:TVTY) has earned a consensus rating of “Buy” from the twelve ratings firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and eight have assigned a buy rating to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $34.00.
TVTY has been the topic of several recent analyst reports. Oppenheimer boosted their target price on Tivity Health from $31.00 to $36.00 in a research report on Thursday, May 9th. Jefferies Financial Group dropped their target price on Tivity Health to $29.00 and set a “buy” rating on the stock in a research report on Wednesday, February 20th. SunTrust Banks dropped their target price on Tivity Health to $28.00 and set a “buy” rating on the stock in a research report on Wednesday, February 20th. Chardan Capital reiterated a “buy” rating and set a $31.00 target price (down previously from $41.00) on shares of Tivity Health in a research report on Friday, February 1st. Finally, Craig Hallum initiated coverage on Tivity Health in a research report on Thursday, April 11th. They set a “buy” rating and a $30.00 target price on the stock.
TVTY traded up $0.08 on Thursday, hitting $18.90. 1,179,810 shares of the company traded hands, compared to its average volume of 1,335,765. The company has a quick ratio of 0.71, a current ratio of 0.86 and a debt-to-equity ratio of 2.13. The company has a market cap of $901.57 million, a PE ratio of 8.08, a P/E/G ratio of 0.78 and a beta of 1.10. Tivity Health has a 12-month low of $16.25 and a 12-month high of $41.46.
In other news, Director Bradley S. Karro purchased 2,900 shares of the stock in a transaction that occurred on Friday, March 22nd. The shares were acquired at an average price of $16.54 per share, for a total transaction of $47,966.00. Following the acquisition, the director now directly owns 24,696 shares in the company, valued at approximately $408,471.84. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Sara Finley purchased 2,000 shares of the stock in a transaction that occurred on Wednesday, March 20th. The stock was purchased at an average price of $17.25 per share, for a total transaction of $34,500.00. The disclosure for this purchase can be found here. Corporate insiders own 1.64% of the company’s stock.
Several institutional investors and hedge funds have recently added to or reduced their stakes in TVTY. Advisor Group Inc. grew its holdings in shares of Tivity Health by 364.2% in the 4th quarter. Advisor Group Inc. now owns 1,142 shares of the company’s stock worth $29,000 after acquiring an additional 896 shares during the period. Shell Asset Management Co. acquired a new stake in shares of Tivity Health in the 1st quarter worth approximately $33,000. Pearl River Capital LLC acquired a new stake in shares of Tivity Health in the 1st quarter worth approximately $36,000. Enlightenment Research LLC acquired a new stake in shares of Tivity Health in the 4th quarter worth approximately $37,000. Finally, Asset Dedication LLC acquired a new stake in shares of Tivity Health in the 1st quarter worth approximately $46,000. Institutional investors and hedge funds own 85.43% of the company’s stock.
Tivity Health Company Profile
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.
Featured Story: How mutual funds make money
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.